Rantum builds German surgical-instruments group with Eurazeo-backed financing
What's the deal? Rantum CapitalDealroom has a profile for this one. Try Dealroom → has secured new growth financing from Eurazeo to fund the build-out of its MedTech group in premium surgical instruments. The financing, raised through the Rantum Private Equity Fund II, backs a string of acquisitions and leaves room for more. Terms were not disclosed.
What's the endgame? Rantum is pursuing a focused buy-and-build in precision surgical instruments. It laid the group's foundation in April 2026 by acquiring Tontarra MedizintechnikDealroom has a profile for this one. Try Dealroom →, then added S. u. A. Martin and Getsch+Hiller.
Why now? The latest financing funds those three deals while creating headroom for further targeted acquisitions, broadening the group's products and customers. The group now spans four sites and nearly 300 employees.
The group manufactures precision surgical instruments across open and minimally invasive surgery, endoscopy, spinal surgery, arthroscopy, laparoscopy, and micro- and neurosurgery. As a fully integrated OEM and contract manufacturer, it covers the whole chain from development to certified approval, supplying leading international MedTech OEMs.
Who's involved? Eurazeo, a European investment group with €40 billion in assets under management, provided the debt financing. Grant Thornton advised Rantum on the group build-out, leading financial and tax due diligence and a combined financial databook; CMSDealroom has a profile for this one. Try Dealroom → and Hogan Lovells CadwaladerDealroom has a profile for this one. Try Dealroom → provided legal counsel.
Christoph Gerber, chief executive officer of the group, called Eurazeo "a strong and highly regarded partner that will support our growth trajectory over the long term."
The signal: A specialist German medtech platform is consolidating fast — three acquisitions in roughly seven months. With institutional backing lined up, Rantum is positioning to keep rolling up a fragmented surgical-instruments market.
Read more: majunke.com
Image credit: Photographer: Meg Lomax
